Supplies of Novo Nordisk’s popular weight-loss drug Wegovy are limited in Germany less than a month after its launch in Europe’s largest drug market, major drug distributors and doctors told Reuters.
https://www.pharmalive.com/wp-content/uploads/2023/04/ReutersWegovy4-13-2023.jpg9001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-08-24 01:04:572023-08-24 10:48:31High demand, low supplies for Novo’s weight-loss drug launch in Germany
